Primary responsibilities include (1) developing and implementing increasingly complex research methodologies, procedures, and criteria and (2) Training individuals and groups on equipment operations, research protocols, and techniques within a specialized laboratory or research area. Other components include aiding in grant- and manuscript-writing, as well as assisting in the development of therapy manual(s) for psilocybin-assisted psychotherapy. Clinical trials worked on include administration of psilocybin or MDMA in the context of mental illness (e.g., Opioid Use Disorder, Methamphetamine Use Disorder, Major Depressive Disorder, Posttraumatic Stress Disorder).

Completed over 100 clinician-administered assessments with individuals with co-occurring PTSD and Substance Use Disorder (SUD), including the CAPS-5, MINI, Modules for Manic and Psychotic Disorders, Timeline Follow back, P4 Suicidality Screener, and SCID-5 Substance Use Disorders module. Also assisted with training other clinical assessors.Other work included SOP development, assistance with IRB applications, survey building in Qualtrics and Teleform, and qualitative coding.

Worked on a number of randomized controlled clinical trials, responsibilities included phone screens (including assessment of alcohol use severity), assisting in converting studies to remote operations in response to COVID-19, researching reliability and validity of various psychometrics, collecting participant data over the phone, and attending team meetings, CAPS-5 supervisions, and CBT-SUD supervisions. Trained to reliability in SCID-IV administration (Overall Kappa Score .96)